Receptor Tyrosine Kinase-like Orphan Receptor 2 (Ror2) Expression Creates a Poised State of Wnt Signaling in Renal Cancer

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2013 Jul 30

PMID 23893409

Citations 17

Authors

Neal R Rasmussen

Tricia M Wright

Samira A Brooks

Kathryn E Hacker

Zufan Debebe

Adam B Sendor

Matthew P Walker

Michael Ben Major

Jennifer Green

Geoffrey M Wahl

W Kimryn Rathmell

Affiliations

Soon will be listed here.

Abstract

Expression of the receptor tyrosine kinase-like orphan receptor 2 (Ror2) has been identified in an increasing array of tumor types and is known to play a role as an important mediator of Wnt signaling cascades. In this study, we aimed to clarify Ror2 interactions with the Wnt pathways within the context of renal cell carcinoma (RCC). An examination of Ror2 expression in primary human RCC tumors showed a significant correlation with several Wnt signaling genes, including the classical feedback target gene Axin2. We provide evidence that Ror2 expression results in a partially activated state for canonical Wnt signaling through an increased signaling pool of β-catenin, leading to an enhancement of downstream target genes following Wnt3a stimulation in both renal and renal carcinoma-derived cells. Additionally, inhibition of low-density lipoprotein receptor-related protein 6 (LRP6) with either siRNA or dickkopf decreased the response to Wnt3a stimulation, but no change was seen in the increased β-catenin pool associated with Ror2 expression, suggesting that LRP6 cofactor recruitment is necessary for a Wnt3a-induced signal but that it does not participate in the Ror2 effect on β-catenin signaling. These results highlight a new role for Ror2 in conveying a tonic signal to stabilize soluble β-catenin and create a poised state of enhanced responsiveness to Wnt3a exogenous signals in RCC.

Citing Articles

Detection of receptor tyrosine kinase-orphan receptor-2 using an electrochemical immunosensor modified with electrospun nanofibers comprising polyvinylpyrrolidone, soy, and gold nanoparticles.

Maleki F, Razmi H, Rashidi M, Yousefi M, Ramazani S, Ghorbani M Mikrochim Acta. 2023; 190(10):418.

PMID: 37770707 DOI: 10.1007/s00604-023-06002-8.

ROR2 regulates self-renewal and maintenance of hair follicle stem cells.

Veltri A, Lang C, Cangiotti G, Chan C, Lien W Nat Commun. 2022; 13(1):4449.

PMID: 35915068 PMC: 9343661. DOI: 10.1038/s41467-022-32239-7.

The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention.

Menck K, Heinrichs S, Baden C, Bleckmann A Cells. 2021; 10(1).

PMID: 33445713 PMC: 7828172. DOI: 10.3390/cells10010142.

ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.

Li R, Liu T, Shi J, Luan W, Wei X, Yu J J Transl Med. 2019; 17(1):428.

PMID: 31878941 PMC: 6933631. DOI: 10.1186/s12967-019-02178-x.

Upregulation of non-canonical Wnt ligands and oxidative glucose metabolism in NASH induced by methionine-choline deficient diet.

Zhu L, Baker S, Shahein A, Choudhury S, Liu W, Bhatia T Trends Cell Mol Biol. 2019; 13:47-56.

PMID: 30853754 PMC: 6407712.

References

Kobayashi M, Shibuya Y, Takeuchi J, Murata M, Suzuki H, Yokoo S . Ror2 expression in squamous cell carcinoma and epithelial dysplasia of the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 107(3):398-406. DOI: 10.1016/j.tripleo.2008.08.018. View

Chitalia V, Foy R, Bachschmid M, Zeng L, Panchenko M, Zhou M . Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nat Cell Biol. 2008; 10(10):1208-16. PMC: 2830866. DOI: 10.1038/ncb1781. View

Billiard J, Way D, Seestaller-Wehr L, Moran R, Mangine A, Bodine P . The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells. Mol Endocrinol. 2004; 19(1):90-101. DOI: 10.1210/me.2004-0153. View

Choi H, Chun Y, Kim T, Park J . HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin. Cancer Res. 2010; 70(24):10101-11. DOI: 10.1158/0008-5472.CAN-10-0505. View

Edris B, Espinosa I, Muhlenberg T, Mikels A, Lee C, Steigen S . ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. J Pathol. 2012; 227(2):223-33. PMC: 3992120. DOI: 10.1002/path.3986. View

OConnell R, Balazs A, Rao D, Kivork C, Yang L, Baltimore D . Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations. PLoS One. 2010; 5(8):e12009. PMC: 2917362. DOI: 10.1371/journal.pone.0012009. View

Afzal A, Rajab A, Fenske C, Oldridge M, Elanko N, Tuysuz B . Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2. Nat Genet. 2000; 25(4):419-22. DOI: 10.1038/78107. View

Al-Shawi R, Ashton S, Underwood C, Simons J . Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development. Dev Genes Evol. 2001; 211(4):161-71. DOI: 10.1007/s004270100140. View

Oldridge M, Fortuna A, Maringa M, Propping P, Mansour S, Pollitt C . Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B. Nat Genet. 2000; 24(3):275-8. DOI: 10.1038/73495. View

10.

Wright T, Brannon A, Gordan J, Mikels A, Mitchell C, Chen S . Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene. 2009; 28(27):2513-23. PMC: 2771692. DOI: 10.1038/onc.2009.116. View

11.

Wright T, Rathmell W . Identification of Ror2 as a hypoxia-inducible factor target in von Hippel-Lindau-associated renal cell carcinoma. J Biol Chem. 2010; 285(17):12916-24. PMC: 2857057. DOI: 10.1074/jbc.M109.073924. View

12.

Laird D, Altshuler-Keylin S, Kissner M, Zhou X, Anderson K . Ror2 enhances polarity and directional migration of primordial germ cells. PLoS Genet. 2012; 7(12):e1002428. PMC: 3245308. DOI: 10.1371/journal.pgen.1002428. View

13.

Henry Ho H, Susman M, Bikoff J, Ryu Y, Jonas A, Hu L . Wnt5a-Ror-Dishevelled signaling constitutes a core developmental pathway that controls tissue morphogenesis. Proc Natl Acad Sci U S A. 2012; 109(11):4044-51. PMC: 3306699. DOI: 10.1073/pnas.1200421109. View

14.

Matsuda T, Nomi M, Ikeya M, Kani S, Oishi I, Terashima T . Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development. Mech Dev. 2001; 105(1-2):153-6. DOI: 10.1016/s0925-4773(01)00383-5. View

15.

Yamagata K, Li X, Ikegaki S, Oneyama C, Okada M, Nishita M . Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression. J Biol Chem. 2011; 287(2):1588-99. PMC: 3256912. DOI: 10.1074/jbc.M111.315127. View

16.

Lu B, Wang Y, Wei X, Rong L, Wei D, Yan C . Expression of WNT-5a and ROR2 correlates with disease severity in osteosarcoma. Mol Med Rep. 2012; 5(4):1033-6. PMC: 3493076. DOI: 10.3892/mmr.2012.772. View

17.

Hsu R, Ho J, Cha T, Yu D, Wu C, Huang W . WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway. PLoS One. 2012; 7(10):e47649. PMC: 3477117. DOI: 10.1371/journal.pone.0047649. View

18.

OConnell M, Fiori J, Xu M, Carter A, Frank B, Camilli T . The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene. 2009; 29(1):34-44. PMC: 2803338. DOI: 10.1038/onc.2009.305. View

19.

Angers S, Moon R . Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol. 2009; 10(7):468-77. DOI: 10.1038/nrm2717. View

20.

Li V, Ng S, Boersema P, Low T, Karthaus W, Gerlach J . Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell. 2012; 149(6):1245-56. DOI: 10.1016/j.cell.2012.05.002. View